Your browser doesn't support javascript.
loading
Tspan6 stimulates the chemoattractive potential of breast cancer cells for B cells in an EV- and LXR-dependent manner.
Molostvov, Guerman; Gachechiladze, Mariam; Shaaban, Abeer M; Hayward, Steven; Dean, Isaac; Dias, Irundika H K; Badr, Nahla; Danial, Irini; Mohammed, Fiyaz; Novitskaya, Vera; Paniushkina, Liliia; Speirs, Valerie; Hanby, Andrew; Nazarenko, Irina; Withers, David R; van Laere, Steven; Long, Heather M; Berditchevski, Fedor.
Afiliação
  • Molostvov G; Institute of Cancer and Genomic Sciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
  • Gachechiladze M; Institute of Cancer and Genomic Sciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK; Department of Clinical and Molecular Pathology, Palacky Univerzity, 7779 00 Olomouc, Czech Republic.
  • Shaaban AM; Institute of Cancer and Genomic Sciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
  • Hayward S; Institute of Cancer and Genomic Sciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
  • Dean I; Institute of Immunology and Immunotherapy, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
  • Dias IHK; Aston Medical Research Institute, Aston Medical School, Aston University, Birmingham B4 7ET, UK.
  • Badr N; Institute of Cancer and Genomic Sciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK; Department of Pathology, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt.
  • Danial I; Institute of Cancer and Genomic Sciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
  • Mohammed F; Institute of Immunology and Immunotherapy, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
  • Novitskaya V; Institute of Cancer and Genomic Sciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
  • Paniushkina L; Faculty of Medicine, Institute for Infection Prevention and Hospital Epidemiology, Medical Center - University of Freiburg, 79106 Freiburg, Germany.
  • Speirs V; Leeds Institute of Medical Research, University of Leeds, St James's University Hospital, Leeds LS9 7TF, UK; Institute of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK.
  • Hanby A; Leeds Institute of Medical Research, University of Leeds, St James's University Hospital, Leeds LS9 7TF, UK.
  • Nazarenko I; Faculty of Medicine, Institute for Infection Prevention and Hospital Epidemiology, Medical Center - University of Freiburg, 79106 Freiburg, Germany; German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Withers DR; Institute of Immunology and Immunotherapy, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
  • van Laere S; Translational Cancer Research Unit Center for Oncological Research, University Antwerp, Antwerp 2610, Belgium.
  • Long HM; Institute of Immunology and Immunotherapy, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: h.m.long@bham.ac.uk.
  • Berditchevski F; Institute of Cancer and Genomic Sciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Electronic address: f.berditchevski@bham.ac.uk.
Cell Rep ; 42(3): 112207, 2023 03 28.
Article em En | MEDLINE | ID: mdl-36867531

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Oxisteróis Limite: Female / Humans Idioma: En Revista: Cell Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Oxisteróis Limite: Female / Humans Idioma: En Revista: Cell Rep Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos